Delaying radiation 50 days or more after surgery in patients with head and neck cancer is associated with increased overall mortality.

News

Patients with a non-thyroid cancer who experience hypothyroidism during cancer treatment with a tyrosine kinase inhibitor (TKI) benefit from significantly increased survival compared with those who have normal thyroid function, according to research presented at the 2017 Annual Meeting of the American Thyroid Association (October 18-22, 2017; British Columbia, Canada).

Read More

By Marilynn Larkin

NEW YORK (Reuters Health) – Thyroidectomy rates in Medicare beneficiaries vary 6.2-fold across the United States, suggesting widely divergent local beliefs and practice patterns about how to manage thyroid cancer, researchers say.

Read More

Approximately 66% of patients with medullary thyroid carcinoma do not receive a complete thyroidectomy or central neck lymph-node dissection, despite recommendations in the American Thyroid Guidelines suggesting combining the two procedures.

Read More

By Megan Brooks

NEW YORK (Reuters Health) - A U.S. study looking at the natural history and growth parameters of small, low-risk papillary thyroid cancers (PTC) supports active surveillance as a management option, the researchers say.

Read More

Subscribe to Head & Neck Cancer